healthcare
healthcare Articles
Moderna made a big step towards a COVID-19 vaccine early on Monday, and investors (and the stock market in general) responded very positively.
Published:
Wedbush took a closer look at some of the companies in its coverage universe that are set to present at ASCO and what the impact may be going forward.
Published:
AIM ImmunoTech shares ticked higher on Thursday after the company announced some big developments with the FDA concerning its treatment for cancer patients with COVID-19.
Published:
Applied DNA Sciences shares made an incredible gain on Thursday after the company announced it had received an update from the FDA concerning its COVID-19 assay kit.
Published:
Novavax shares jumped on Tuesday after the company announced that it would be receiving a sizable investment to further produce its COVID-19 vaccine.
Published:
CymaBay Therapeutics shares more than doubled on Tuesday after the company announced its first-quarter results, along with a corporate update.
Published:
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
MyoKardia shares made an incredible gain on Monday after the company announced positive results from its late-stage pivotal clinical trial of mavacamten.
Published:
Cellect Biotechnology shares nearly doubled to start the week after the company announced progress with its bone marrow transplantation process.
Published:
These are five of the best stocks in a sector that has been humming along in what has been a turbulent year. They are all included on the Goldman Sachs Conviction List too.
Published:
Amarin Corp. PLC (NASDAQ: AMRN) plans to mount a vigorous and speedy appeal of a U.S. District Court ruling that blocked its patents on the medication Vascepa, the company’s chief executive says....
Published:
Gilead Sciences took another big step forward in its treatment for COVID-19 on Friday when a Japanese regulatory body approved that treatment.
Published:
BioNTech and Pfizer stocks each made a handy gain on Monday after the companies announced the beginning of human trials for a COVID-19 vaccine.
Published:
Regeneron Pharmaceuticals reported its first-quarter financial results before the markets opened on Tuesday. While the earnings were important, and fairly positive, more investors seemed interested...
Published: